Jardiance Duo迅糖達

Jardiance Duo Indications/Uses

empagliflozin + metformin

Manufacturer:

Boehringer Ingelheim

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Indications/Uses
Jardiance Duo is indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise: in patients insufficiently controlled on their maximally tolerated dose of metformin alone; in combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products; in patients already being treated with the combination of empagliflozin and metformin as separate tablets.
For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the population studied, see Precautions, Interactions and Pharmacology: Pharmacodynamics under Actions.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in